The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dolutegravir Market Research Report 2025
Synopsis
The global Dolutegravir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dolutegravir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dolutegravir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dolutegravir include ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs and Adcock Ingram Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dolutegravir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir.
Report Scope
The Dolutegravir market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dolutegravir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dolutegravir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ViiV Healthcare (GSK)
Shanghai Desano Pharmaceuticals
Mylan
Aurobindo Pharma
LAURUS Labs
Adcock Ingram Limited
Segment by Type
10mg Tablets
50mg Tablets
Segment by Application
Prevent HIV Infection Following Potential Exposure
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dolutegravir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dolutegravir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Dolutegravir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dolutegravir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dolutegravir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dolutegravir include ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs and Adcock Ingram Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dolutegravir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir.
Report Scope
The Dolutegravir market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dolutegravir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dolutegravir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ViiV Healthcare (GSK)
Shanghai Desano Pharmaceuticals
Mylan
Aurobindo Pharma
LAURUS Labs
Adcock Ingram Limited
Segment by Type
10mg Tablets
50mg Tablets
Segment by Application
Prevent HIV Infection Following Potential Exposure
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dolutegravir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dolutegravir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dolutegravir Market Overview
1.1 Product Overview and Scope of Dolutegravir
1.2 Dolutegravir Segment by Type
1.2.1 Global Dolutegravir Market Value Comparison by Type (2024-2030)
1.2.2 10mg Tablets
1.2.3 50mg Tablets
1.3 Dolutegravir Segment by Application
1.3.1 Global Dolutegravir Market Value by Application: (2024-2030)
1.3.2 Prevent HIV Infection Following Potential Exposure
1.3.3 Others
1.4 Global Dolutegravir Market Size Estimates and Forecasts
1.4.1 Global Dolutegravir Revenue 2019-2030
1.4.2 Global Dolutegravir Sales 2019-2030
1.4.3 Global Dolutegravir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dolutegravir Market Competition by Manufacturers
2.1 Global Dolutegravir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dolutegravir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dolutegravir Average Price by Manufacturers (2019-2024)
2.4 Global Dolutegravir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dolutegravir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dolutegravir, Product Type & Application
2.7 Dolutegravir Market Competitive Situation and Trends
2.7.1 Dolutegravir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dolutegravir Players Market Share by Revenue
2.7.3 Global Dolutegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dolutegravir Retrospective Market Scenario by Region
3.1 Global Dolutegravir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dolutegravir Global Dolutegravir Sales by Region: 2019-2030
3.2.1 Global Dolutegravir Sales by Region: 2019-2024
3.2.2 Global Dolutegravir Sales by Region: 2025-2030
3.3 Global Dolutegravir Global Dolutegravir Revenue by Region: 2019-2030
3.3.1 Global Dolutegravir Revenue by Region: 2019-2024
3.3.2 Global Dolutegravir Revenue by Region: 2025-2030
3.4 North America Dolutegravir Market Facts & Figures by Country
3.4.1 North America Dolutegravir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dolutegravir Sales by Country (2019-2030)
3.4.3 North America Dolutegravir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dolutegravir Market Facts & Figures by Country
3.5.1 Europe Dolutegravir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dolutegravir Sales by Country (2019-2030)
3.5.3 Europe Dolutegravir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dolutegravir Market Facts & Figures by Country
3.6.1 Asia Pacific Dolutegravir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dolutegravir Sales by Country (2019-2030)
3.6.3 Asia Pacific Dolutegravir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dolutegravir Market Facts & Figures by Country
3.7.1 Latin America Dolutegravir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dolutegravir Sales by Country (2019-2030)
3.7.3 Latin America Dolutegravir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dolutegravir Market Facts & Figures by Country
3.8.1 Middle East and Africa Dolutegravir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dolutegravir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dolutegravir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dolutegravir Sales by Type (2019-2030)
4.1.1 Global Dolutegravir Sales by Type (2019-2024)
4.1.2 Global Dolutegravir Sales by Type (2025-2030)
4.1.3 Global Dolutegravir Sales Market Share by Type (2019-2030)
4.2 Global Dolutegravir Revenue by Type (2019-2030)
4.2.1 Global Dolutegravir Revenue by Type (2019-2024)
4.2.2 Global Dolutegravir Revenue by Type (2025-2030)
4.2.3 Global Dolutegravir Revenue Market Share by Type (2019-2030)
4.3 Global Dolutegravir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dolutegravir Sales by Application (2019-2030)
5.1.1 Global Dolutegravir Sales by Application (2019-2024)
5.1.2 Global Dolutegravir Sales by Application (2025-2030)
5.1.3 Global Dolutegravir Sales Market Share by Application (2019-2030)
5.2 Global Dolutegravir Revenue by Application (2019-2030)
5.2.1 Global Dolutegravir Revenue by Application (2019-2024)
5.2.2 Global Dolutegravir Revenue by Application (2025-2030)
5.2.3 Global Dolutegravir Revenue Market Share by Application (2019-2030)
5.3 Global Dolutegravir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ViiV Healthcare (GSK)
6.1.1 ViiV Healthcare (GSK) Corporation Information
6.1.2 ViiV Healthcare (GSK) Description and Business Overview
6.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ViiV Healthcare (GSK) Dolutegravir Product Portfolio
6.1.5 ViiV Healthcare (GSK) Recent Developments/Updates
6.2 Shanghai Desano Pharmaceuticals
6.2.1 Shanghai Desano Pharmaceuticals Corporation Information
6.2.2 Shanghai Desano Pharmaceuticals Description and Business Overview
6.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolio
6.2.5 Shanghai Desano Pharmaceuticals Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Dolutegravir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Dolutegravir Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Corporation Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Dolutegravir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Dolutegravir Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 LAURUS Labs
6.5.1 LAURUS Labs Corporation Information
6.5.2 LAURUS Labs Description and Business Overview
6.5.3 LAURUS Labs Dolutegravir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 LAURUS Labs Dolutegravir Product Portfolio
6.5.5 LAURUS Labs Recent Developments/Updates
6.6 Adcock Ingram Limited
6.6.1 Adcock Ingram Limited Corporation Information
6.6.2 Adcock Ingram Limited Description and Business Overview
6.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Adcock Ingram Limited Dolutegravir Product Portfolio
6.6.5 Adcock Ingram Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dolutegravir Industry Chain Analysis
7.2 Dolutegravir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dolutegravir Production Mode & Process
7.4 Dolutegravir Sales and Marketing
7.4.1 Dolutegravir Sales Channels
7.4.2 Dolutegravir Distributors
7.5 Dolutegravir Customers
8 Dolutegravir Market Dynamics
8.1 Dolutegravir Industry Trends
8.2 Dolutegravir Market Drivers
8.3 Dolutegravir Market Challenges
8.4 Dolutegravir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Dolutegravir Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Dolutegravir Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Dolutegravir Market Competitive Situation by Manufacturers in 2023
Table 4. Global Dolutegravir Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Dolutegravir Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Dolutegravir Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Dolutegravir Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Dolutegravir Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Dolutegravir, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Dolutegravir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dolutegravir, Product Type & Application
Table 12. Global Key Manufacturers of Dolutegravir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dolutegravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dolutegravir as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dolutegravir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Dolutegravir Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Dolutegravir Sales Market Share by Region (2019-2024)
Table 19. Global Dolutegravir Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Dolutegravir Sales Market Share by Region (2025-2030)
Table 21. Global Dolutegravir Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Dolutegravir Revenue Market Share by Region (2019-2024)
Table 23. Global Dolutegravir Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Dolutegravir Revenue Market Share by Region (2025-2030)
Table 25. North America Dolutegravir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Dolutegravir Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Dolutegravir Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Dolutegravir Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Dolutegravir Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Dolutegravir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Dolutegravir Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Dolutegravir Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Dolutegravir Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Dolutegravir Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Dolutegravir Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Dolutegravir Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Dolutegravir Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Dolutegravir Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Dolutegravir Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Dolutegravir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Dolutegravir Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Dolutegravir Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Dolutegravir Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Dolutegravir Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Dolutegravir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Dolutegravir Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Dolutegravir Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Dolutegravir Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Dolutegravir Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Dolutegravir Sales (K Pcs) by Type (2019-2024)
Table 51. Global Dolutegravir Sales (K Pcs) by Type (2025-2030)
Table 52. Global Dolutegravir Sales Market Share by Type (2019-2024)
Table 53. Global Dolutegravir Sales Market Share by Type (2025-2030)
Table 54. Global Dolutegravir Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Dolutegravir Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Dolutegravir Revenue Market Share by Type (2019-2024)
Table 57. Global Dolutegravir Revenue Market Share by Type (2025-2030)
Table 58. Global Dolutegravir Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Dolutegravir Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Dolutegravir Sales (K Pcs) by Application (2019-2024)
Table 61. Global Dolutegravir Sales (K Pcs) by Application (2025-2030)
Table 62. Global Dolutegravir Sales Market Share by Application (2019-2024)
Table 63. Global Dolutegravir Sales Market Share by Application (2025-2030)
Table 64. Global Dolutegravir Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Dolutegravir Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Dolutegravir Revenue Market Share by Application (2019-2024)
Table 67. Global Dolutegravir Revenue Market Share by Application (2025-2030)
Table 68. Global Dolutegravir Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Dolutegravir Price (USD/Pcs) by Application (2025-2030)
Table 70. ViiV Healthcare (GSK) Corporation Information
Table 71. ViiV Healthcare (GSK) Description and Business Overview
Table 72. ViiV Healthcare (GSK) Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. ViiV Healthcare (GSK) Dolutegravir Product
Table 74. ViiV Healthcare (GSK) Recent Developments/Updates
Table 75. Shanghai Desano Pharmaceuticals Corporation Information
Table 76. Shanghai Desano Pharmaceuticals Description and Business Overview
Table 77. Shanghai Desano Pharmaceuticals Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Shanghai Desano Pharmaceuticals Dolutegravir Product
Table 79. Shanghai Desano Pharmaceuticals Recent Developments/Updates
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Mylan Dolutegravir Product
Table 84. Mylan Recent Developments/Updates
Table 85. Aurobindo Pharma Corporation Information
Table 86. Aurobindo Pharma Description and Business Overview
Table 87. Aurobindo Pharma Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Aurobindo Pharma Dolutegravir Product
Table 89. Aurobindo Pharma Recent Developments/Updates
Table 90. LAURUS Labs Corporation Information
Table 91. LAURUS Labs Description and Business Overview
Table 92. LAURUS Labs Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. LAURUS Labs Dolutegravir Product
Table 94. LAURUS Labs Recent Developments/Updates
Table 95. Adcock Ingram Limited Corporation Information
Table 96. Adcock Ingram Limited Description and Business Overview
Table 97. Adcock Ingram Limited Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Adcock Ingram Limited Dolutegravir Product
Table 99. Adcock Ingram Limited Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Dolutegravir Distributors List
Table 103. Dolutegravir Customers List
Table 104. Dolutegravir Market Trends
Table 105. Dolutegravir Market Drivers
Table 106. Dolutegravir Market Challenges
Table 107. Dolutegravir Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dolutegravir
Figure 2. Global Dolutegravir Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Dolutegravir Market Share by Type in 2023 & 2030
Figure 4. 10mg Tablets Product Picture
Figure 5. 50mg Tablets Product Picture
Figure 6. Global Dolutegravir Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Dolutegravir Market Share by Application in 2023 & 2030
Figure 8. Prevent HIV Infection Following Potential Exposure
Figure 9. Others
Figure 10. Global Dolutegravir Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Dolutegravir Market Size (2019-2030) & (US$ Million)
Figure 12. Global Dolutegravir Sales (2019-2030) & (K Pcs)
Figure 13. Global Dolutegravir Average Price (USD/Pcs) & (2019-2030)
Figure 14. Dolutegravir Report Years Considered
Figure 15. Dolutegravir Sales Share by Manufacturers in 2023
Figure 16. Global Dolutegravir Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Dolutegravir Players: Market Share by Revenue in 2023
Figure 18. Dolutegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Dolutegravir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Dolutegravir Sales Market Share by Country (2019-2030)
Figure 21. North America Dolutegravir Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Dolutegravir Sales Market Share by Country (2019-2030)
Figure 25. Europe Dolutegravir Revenue Market Share by Country (2019-2030)
Figure 26. Germany Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Dolutegravir Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Dolutegravir Revenue Market Share by Region (2019-2030)
Figure 33. China Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Dolutegravir Sales Market Share by Country (2019-2030)
Figure 44. Latin America Dolutegravir Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Dolutegravir Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Dolutegravir Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Dolutegravir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Dolutegravir by Type (2019-2030)
Figure 54. Global Revenue Market Share of Dolutegravir by Type (2019-2030)
Figure 55. Global Dolutegravir Price (USD/Pcs) by Type (2019-2030)
Figure 56. Global Sales Market Share of Dolutegravir by Application (2019-2030)
Figure 57. Global Revenue Market Share of Dolutegravir by Application (2019-2030)
Figure 58. Global Dolutegravir Price (USD/Pcs) by Application (2019-2030)
Figure 59. Dolutegravir Value Chain
Figure 60. Dolutegravir Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
